| Date Filed | Type | Description |
| 06/08/2023 |
4
| Cline Darren S (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2023 |
4
| Cline Darren S (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 22,000 options to buy
@ $31.11, valued at
$684.4k
|
|
| 03/08/2023 |
3
| Cline Darren S (Director) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
| 04/04/2022 |
4
| Cline Darren S (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 66,831 shares
@ $0 |
|
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2021 |
4
| Cline Darren S (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 42,191 options to buy
@ $16, valued at
$675.1k
|
|
| 10/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Cline Darren S (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Unknown transaction of 35,468 shares
@ $0 |
|
| 06/08/2020 |
4
| Cline Darren S (U.S. Chief Commercial Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Granted 177,180 options to buy
@ $0
Granted 106,320 options to buy
@ $0 |
|
| 05/29/2020 |
4
| Cline Darren S (U.S. Chief Commercial Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Exercised 7,356 shares
@ $0.0012, valued at
$8.8
Paid exercise price by delivering 1,800 shares
@ $10.54, valued at
$19k
Exercised 7,356 options
@ $0 |
|
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2019 |
4
| Cline Darren S (U.S. Chief Commercial Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Granted 29,424 shares
@ $0.0013, valued at
$38.3
Granted 54,192 options to buy
@ $0
Granted 98,040 options to buy
@ $0 |
|
| 05/01/2019 |
3
| Cline Darren S (U.S. Chief Commercial Officer) has filed a Form 3 on GW PHARMACEUTICALS PLC |
| 11/30/2018 |
4
| Cline Darren S (EVP, Commercial) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 7,000 shares
@ $62.88, valued at
$440.2k
|
|
| 11/21/2018 |
4
| Cline Darren S (EVP, Commercial) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 4,167 shares
@ $56.6845, valued at
$236.2k
|
|
| 09/04/2018 |
4
| Cline Darren S (EVP, Commercial) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 18,644 shares
@ $0
Granted 1,301 options to buy
@ $76.86, valued at
$100k
Granted 42,984 options to buy
@ $76.86, valued at
$3.3M
|
|
| 08/29/2018 |
4
| Cline Darren S (EVP, Commercial) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 4,784 shares
@ $74.2318, valued at
$355.1k
|
|
| 06/22/2018 |
4
| Cline Darren S (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 20,468 shares
@ $0 |
|
| 06/14/2018 |
4
| Cline Darren S (EVP, Commercial) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 892 shares
@ $69, valued at
$61.5k
Sold 268 shares
@ $69, valued at
$18.5k
Sold 926 shares
@ $69, valued at
$63.9k
Sold 8,000 shares
@ $69, valued at
$552k
Sold 718 shares
@ $68.9, valued at
$49.5k
Sold 1,250 shares
@ $69.027, valued at
$86.3k
Exercised 268 options to buy
@ $15.46, valued at
$4.1k
Exercised 892 options to buy
@ $16.41, valued at
$14.6k
Exercised 926 options to buy
@ $26.1, valued at
$24.2k
Exercised 8,000 options to buy
@ $31.37, valued at
$251k
|
|
| 05/11/2018 |
4
| Cline Darren S (EVP, Commercial) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 9,000 shares
@ $55.3314, valued at
$498k
Exercised 2,000 options to buy
@ $15.46, valued at
$30.9k
Exercised 7,000 options to buy
@ $16.41, valued at
$114.9k
|
|
| 05/07/2018 |
4
| Cline Darren S (EVP, Commercial) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 4,000 shares
@ $53.8096, valued at
$215.2k
|
|
| 04/26/2018 |
3
| Cline Darren S (Director) has filed a Form 3 on STEMLINE THERAPEUTICS INC |
| 03/22/2018 |
4
| Cline Darren S (See Remarks) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 8,333 options to buy
@ $34.2, valued at
$285k
|
|
| 02/07/2018 |
4
| Cline Darren S (EVP, Commercial) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Disposed/sold 1,399 shares
@ $55.5796, valued at
$77.8k
|
|
| 09/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|